Novonesis (Novozymes) B (STU:NZM2)
€ 56.62 0.52 (0.93%) Market Cap: 26.38 Bil Enterprise Value: 28.11 Bil PE Ratio: 39.62 PB Ratio: 2.44 GF Score: 97/100

Novozymes A/S Annual Shareholders Meeting Transcript

Feb 26, 2020 / 03:00PM GMT
Release Date Price: €43.04
JÃ;rgen Buhl Rasmussen;S;Independent Chairman
Novozymes A

¸ - /-

(foreign language) [Interpreted] I think we are ready to begin today's meeting, the AGM of Novozymes A/S shareholders. I'd like to welcome you to the Ballerup Super Arena, to our ordinary Annual General Meeting 2020. We, on the Board, look forward to this afternoon. We look forward to offering you refreshments after the meeting.

I have been looking forward to today's meeting. It's the first time you will be saying hello to our new CEO, Ester Baiget, but we'll get back to that. We will also be talking about what we have been spending our time on during 2019 in Novozymes to get closer to the ambition and the targets defined for us. We will also tell you our plans for 2020 and the ensuing years to have a positive effect on the world or to make sure an attractive return is paid to all shareholders and stakeholders.

You probably know that I am Jorgen Rasmussen, I'm the Chairman of the Board of Novozymes. They are the members of the Board: Agnete Raaschou-Nielsen, Vice Chair; Kasim

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot